Search

Your search keyword '"Martin Bitzan"' showing total 108 results

Search Constraints

Start Over You searched for: Author "Martin Bitzan" Remove constraint Author: "Martin Bitzan"
108 results on '"Martin Bitzan"'

Search Results

1. The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome

2. The genomic landscape of rare disorders in the Middle East

3. Rapid whole genome sequencing of critically ill pediatric patients from genetically underrepresented populations

4. Case Report: Guillain-Barré Syndrome as Primary Presentation of Systemic Lupus Erythematosus (SLE-GBS) in a Teenage Girl

5. The Canadian childhood nephrotic syndrome (CHILDNEPH) study: report on mid-study feasibility, recruitment and main measures

6. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review

7. Case Report: CMV-Associated Congenital Nephrotic Syndrome

8. Clinical Characteristics and Outcome of Canadian Patients Diagnosed With Atypical Hemolytic Uremic Syndrome

9. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.

10. Setting New Directions for Research in Childhood Nephrotic Syndrome: Results From a National Workshop

11. Rituximab in Minimal Change Disease

12. The Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project: Overview of Design and Methods

14. Recurrent Focal Segmental Glomerulosclerosis: A Discrete Clinical Entity

15. Relapsing and refractory peritoneal dialysis peritonitis caused by Corynebacterium amycolatum

16. Postinfectious Hemolytic Uremic Syndrome

17. The Genomic Landscape of Rare Disorders in the Middle East

18. Guillain Barré Syndrome as Primary Presentation of Systemic Lupus Erythematosus (SLE-GBS) in a Teenage Girl: A Case Report

20. Renal tubular dysgenesis and microcolon, a novel association. Report of three cases

21. Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic review

22. Renal Tubular Acidosis

23. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review

24. Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Emergency Departments

25. Clinical Characteristics and Outcome of Canadian Patients Diagnosed With Atypical Hemolytic Uremic Syndrome

26. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome

27. Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion—rapid remission following complement blockade

28. Influenza-associated thrombotic microangiopathies

29. Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin–producing Escherichia coli–infected Children

30. Complement depletion and Coombs positivity in pneumococcal hemolytic uremic syndrome (pnHUS). Case series and plea to revisit an old pathogenetic concept

31. Update in Pediatric Nephrology

32. Setting New Directions for Research in Childhood Nephrotic Syndrome: Results From a National Workshop

33. Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Glomerulonephritis in Adults

34. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis

35. Substantial practice variation exists in the management of childhood nephrotic syndrome

36. An international consensus approach to the management of atypical hemolytic uremic syndrome in children

37. TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation

38. Native nephrectomy prior to pediatric kidney transplantation: biological and clinical aspects

39. Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes

40. Treatment of Typical (Enteropathic) Hemolytic Uremic Syndrome

41. Rituximab (B-cell depleting antibody) associated lung injury (RALI): A pediatric case and systematic review of the literature

42. Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution

43. Manual of Pediatric Nephrology

44. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis

45. Escherichia coliO157 Fails to Induce a Long‐Lasting Lipopolysaccharide‐Specific, Measurable Humoral Immune Response in Children with Hemolytic‐Uremic Syndrome

46. Rituximab in Minimal Change Disease

47. Manual of Pediatric Nephrology

48. Reply: Rituximab-induced pneumonitis: Steroid therapy or not?

49. Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of nephrotic syndrome in children

50. Inhibition of Helicobacter pylori and Helicobacter mustelae Binding to Lipid Receptors by Bovine Colostrum

Catalog

Books, media, physical & digital resources